Beneficient (BENFW) Common Equity (2020 - 2025)

Beneficient's Common Equity history runs 6 years deep, the most recent figure standing at -$128.6 million for Q4 2025.

• In Q4 2025, Common Equity fell 1001.59% year-over-year to -$128.6 million; the TTM figure through Dec 2025 stood at -$128.6 million (down 1001.59% YoY), while the FY2025 annual figure was -$34.9 million, up 81.82% from the prior year.
• Common Equity came in at -$128.6 million for Q4 2025 at Beneficient, up from -$142.8 million in the prior quarter.
• In the past five years, Common Equity ranged from a high of $1.9 billion in Q1 2022 to a low of -$192.1 million in Q1 2024.
• A 5-year average of $636.1 million and a median of $14.3 million in 2024 frame the typical range for Common Equity.
• Across the five-year window, Common Equity jumped 258.92% in 2024 and sank 1001.59% in 2025, its largest moves.
• Beneficient's Common Equity stood at $1.1 billion in 2021, then jumped by 65.19% to $1.8 billion in 2022, then plunged by 99.78% to $4.0 million in 2023, then surged by 258.92% to $14.3 million in 2024, then tumbled by 1001.59% to -$128.6 million in 2025.
• According to Business Quant data, Common Equity over the past three periods registered -$128.6 million, -$142.8 million, and -$120.4 million for Q4 2025, Q3 2025, and Q2 2025 respectively.

Peer Comparison